Prevalent infectious diseases in patients with HIV/AIDS in Ethiopia

Ethiopian Medical Journal

Volumn 41, Issue 2, 2003, Pages 189-203

  Wolday, Dawit ^a   Messele, Tsehaynesh ^a  

^a Ethio Netherlands AIDS Research Project ENARP   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS RELATED COMPLEX; CLASSIFICATION; ETHIOPIA; HETEROSEXUALITY; HUMAN; MYCOBACTERIOSIS; MYCOSIS; PARASITOSIS; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ETHIOPIA; HETEROSEXUALITY; HUMANS; MYCOBACTERIUM INFECTIONS; MYCOSES; PARASITIC DISEASES; PREVALENCE; SEXUALLY TRANSMITTED DISEASES; VIRUS DISEASES;

EID: 3543100894     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Kloos H, Zein A. Zein. The Ecology of Health and Disease in Ethiopia, Westview press, 1992.
2. UNAIDS. The current global situation of HIV/AIDS pandemic. UNAIDS Report, 2001.
3. Tsega E. Serologcal survey of HIV infection in Ethiopia. Ethiop Med J 1988;26:179-84.
4. Lester FT, Ayehuni S, Zewdie D. Acquired immunodeficiency syndrome: Seven AIDS cases in Addis Ababa Hospital. Ethiop Med J 1988;26:139-47.
5. Kefenie H, Butto S, Dekure D, et al. Serological survey of HIV in Ethiopia. J Med Virol 1989;28:21-4.
6. Ministry of Health. AIDS in Ethiopia. Disease Prevention and Control Department, Ministry of Health, Addis Ababa, Ethiopia. 2002;4.
7. Shabir I and Larson CP. Urban to rural routes of HIV infection spread in Ethiopia. J Trop Med Hyg 1995;98:338-42.
8. Abebe Y, Schaap A, Mamo G, et al., Urban and rural HIV prevalence in over 72,000 male army recruits, Ethiopia, 1999-2000. AIDS, 2003, In press.
9. Abebe A. HIV-1 subtype C in Ethiopia: Genotypic and phenotypic variation. PhD Dissertation, Univ. of Amsterdam, Amsterdam, 2000.
10. Tsega E. The demographic, social and clinical presentation of 100 Ethiopian patients with HIV infection. Ethiop Med J. 1990;28:81-8.
11. Kassa E, Rinke de Wit TF, Hailu E, et al. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 1999;13:381-9.
12. Bedri A, Lulseged S. Clinical description of children with HIV/AIDS admitted at a referral hospital in Addis Ababa. Ethiop Med J. 2001;39:203-11.
13. Wolday D, Hailu B, Sanders E, et al. Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians. Int J Tubercle Lung Dis 2003;7:110-6.
14. Kefenie H, Zewdie D, Desta B, et al. The prevalence of HIV antibodies in 106 tuberculosis patients. Ethiop J Health Dev. 1990;4:197-200.
15. Gellette A, Kebede D, Berhane Y. Tuberculosis and HIV infection in southern Ethiopia. Ethiop J Health Dev. 1997;11:51-9.
16. Demssie M, Lindtgorn B, Tegbaru B. Human immunodeficiency virus (HIV) infection in tuberculosis patients in Addis Ababa. Ethiop J Health Dev 2000;14:277-82.
17. Feleke Y, Abdulkader J, Aderaye G. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients. East Afr Med J 1999;76:361-4.
18. Palme B, Gudetta B, Degefu H, Muhe L, Bruchfeld J, Giesecke J. A controlled estimate of the risk of HIV infection in Ethiopian children with tuberculosis. Epidemiol Infect 2001;127:517-25.
19. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002;40:704-6.
20. Elias D, Wolday D, Akuffo H, Petros B, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacilli Calmette-Guérin (BCG) vaccination. Clin Exp Immunol 2001;123:219-25.
21. Bruchfeld J, Aderaye G, Palme IB, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol. 2002;40:1636-43.
22. Aderaye G, Melaku K, Zenebe G. Pleural tuberculosis in patients infected with HIV in Addis Ababa. Cent Afr J Med 1996;42:337-40.
23. Madebo T, Nysaeter G, Lindtgorn B. HIV infection and malnutrition change the clinical and radiological features of pulmonary tuberculosis. Scan J Infect Dis 1997;29:355-9.
24. 23a. Bruchfeld J, Aderaye G, Palme IB, et al. Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics. Scand J Infect Dis. 2002;34:331-7.
25. Gessesse B, Mulugeta E. Multiforme skin lesions in Yekatit 12 Hospital, 1976-1994. Ethiop Med J 2000;38:43-7.
26. Mitike G, Kebede D, Yeneneh H. HIV infection and anti-tuberculosis drug resistance among pulmonary tuberculosis patients in Harar Tuberculosis Center, Ethiopia. East Afr Med J. 1997;74:154-7.
27. Abate G. In vitro susceptibility of clinical isolates of M. tuberculosis from patients in Addis Ababa to first line, second line and experimental drugs. M.Sc. thesis, AAU, 1995.
28. Gessesse B, Mulugetta E. Stevens Johonsons Syndrome in Yekatit-12 Hospital 1976-94 [Abstract]. Ethiop Med J. 1994;32:290-1.
29. Cosivi O, Grange JM, Daborn CJ, et al. Zoonotic tuberculosis due to M. bovis in developing countries. Emerg Infect Dis. 1998;4:59-70.
30. Tekle-Haymanot R, Frommel D, Tadesse T, Verdier M, Denis F. A survey of HTLV-1 and HIV-1 in Ethiopian leprosy patients. AIDS 1991;5:108-10.
31. Frommel D, Tekle-Haymanot R, Verdier M, Negesse Y, Bulto T, Denis F. HIV infection and leprosy: a four-year survey in Ethiopia. Lancet. 1994;344:165-6.
32. Gebre S, Saunderson P, Messele T, Byass P. The effect of HIV status on the clinical picture of leprosy: a prospective study in Ethiopia. Lep Rev 2000;71:338-43.
33. Aderaye G. Community acquired pneumonia in adults in Addis Ababa: etiologic agents and the impact of HIV infection. Tuber Lung Dis 1994;75:308-12.
34. Wolday D. Increased incidence of multi-drug resistance among Salmonellae in Ethiopia. J Antimicrob Chemother 1998;41:421-3.
35. Wolday D, Seyoum B. Pleural empyema due to Salmonella paratyphi C in a patient with AIDS. Internat Health Trop Med 1997;2:1140-2.
36. Wolday D, Erge W. Antimicrobial sensitivity pattern of Salmonella: comparison of isolates from HIV-infected and HIV-uninfected patients. Trop Doctor. 1998;28:139-41.
37. Asrat D. Bacterial etiologic agents Of diarrhoea. Msc thesis, AAU, 1994.
38. Asrat D, Hathaway A, Sjogren E, Ekwal E, Kaijser B. The serotype distribution of Campylobacter jejuni and C. coli isolated from patients with diarrhoea and controls at Tiklur Anbessa Hospital, Addis Ababa, Ethiopia. Epidemiol Infect 1997;118:91-5.
39. 37a. Awole M, Gebre-Selassie S, Kassa T, Kibru G. Isolation of potential bacterial pathogens from stool of HIV-infected and HIV-non-infected patients and their susceptibility patterns in Jimma Hospital, Squth-West Ethiopia. Ethiop Med J 2002;40:353-64.
40. Assefa A. Viral diseases in Ethiopia: a review. East Afr Med J. 1993;70:624-6.
41. Quana'a P, Zenebe M. AIDS amongst ophthalmic population [Abstract]. Ethiop Med J. 1992;30:247.
42. Daniel A. Occular findings in Ethiopian patients with the AIDS [Abstract]. Ethiop Med J 1992;30:248.
43. Bayu S, Alemayehu W. Clinical profile of herpes zooster ophthalmicus in Ethiopians [Abstract]. Clin Infect Dis 1997;24:1256-60.
44. Bayu S, Alemayehu W. Evaluation of Hutchinon's sign in HIV associated herpes zooster ophthalmicus [Abstract]. Ethiop Med J. 1996;34:259.
45. Tsega E. Viral hepatitis and chronic liver disease in Ethiopia: epidemiological and clinical aspects. PhD thesis, University of Lund, Malmo, Sweden, 1991.
46. Frommel D, Tekle-Haymanot R, Berhe N, et al. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg. 1993;49:435-9.
47. Alkan ML, Maayan S, Belmaker I, Arbeli Y, Mani N, Yshai PB. Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia. Isr J Med Sci. 1993;29:390-2.
48. Yohannes G, Molla K, Rahlenbeck S. Infection with hepatitis B virus, HIV and sypillis in North-West Ethiopia: prevalence of serological markers in blood donors [Abstract]. Ethiop Med J. 1995;33:204.
49. Ayele W, Nokes DJ, Abebe A, et al. Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol. 2002;68:12-7.
50. Mengesha B. Cryptosporidiasis among medical patients with the AIDS in Tikur-Anbessa Teaching Hospital, Ethiopia. East Afr Med J. 1994;71:376-8.
51. Fisseha B, Petros B, WoldeMichael T. Cryptosporidium and other parasites in Ethiopian AIDS patients with chronic diarrhoea. East Afr Med J 1998;75:100-1.
52. Kebede A, Endeshaw T, Verwejj JJ, et al. Entamoeba histolytica/dispar among HIV/AIDS study cohort participants in Wonji and Akaki: a preliminary observation [Abstract]. XXXVIIth Annual Medical Conference, Ethiopian Medical Association, 2001.
53. Berhe N, Hailu A, Wolday D, Negesse Y, Cenini P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with HIV-1. Trans R Soc Trop Med Hyg. 1995;89:205-7.
54. Berhe N, Hailu A, Gemetchu T. HIV and recurence of cutaneous leishmaniasis long after healed local cutaneous leishmaniasis due to Leishmania aethiopica. Trans R Soc Trop Med Hyg. 1995;89:400-1.
55. Wolday D, Berhe N, Hannah A, Desjeux P, Britton S. Emerging Leishmania-HIV coinfection in Africa. Med Microbiol Immunol 2001;190:65-7.
56. Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 1999;15:182-7.
57. Berhe N, Wolday D, Hailu A, et al. HIV viral load and response-to antileishmanial chemotherapy in co-infected patients. AIDS 1999;13:1921-5.
58. Ritmeijer K, Veeken H, Melaku G, et al. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg 2001;95:668-72.
59. Guebre-xabier M, Nurilign A, Gebre-Hiwot A, et al. Seroepidemiological survey of Toxoplasma gondii infection in Ethiopia. Ethiop Med J. 1993;31:201-8.
60. WoldeMichael T, Fontanet AL, Sahlu T, et al. Evaluation of the Eiken latex agglutination test to detect anti-Toxoplasma antibodies and seroprevalence of toxoplasmosis among Akaki factory workers, Addis Ababa, Ethiopia. Trans Roy Soc Trop Med Hyg 1998;92:401-3.
61. Fontanet AL, Woldemichael T, Sahlu T, et al. Epidemiology of HIV and Schistosoma mansoni infections among sugar estate residents in Ethiopia. Ann Trop Med Parasitol 2000;94:145-55.
62. Fontanet AL, Sahlu T, Rinke de Wit T, et al. Epidemiology of infections with intestinal parasites and human immunodeficiency virus (HIV) among sugar-estate residents in Ethiopia. Ann Trop Med Parasitol 2000;94;269-78.
63. Fesseha B. Parsitic etiologic agents of diarrhoea in AIDS patients. MSc thesis. AAU, 1996.
64. Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel:relevance to helminthic infections? Clin Exp Immunol 1996;103:329-43.
65. Bentwich Z, Kalinkovitz A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91.
66. Wolday D, Mayaan S, Mariam ZG, et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr 2002;31:56-62.
67. Birku Y, Bjorkman A, Mekonnen E, Wolday D. Delayed clearance of Plasmodium falciparum in patients with HIV co-infection treated with artemisinin. Ethiop Med J 2002;40(Suppl. 1):17-26.
68. Xiao L, Owen S, Rudolph L, Lal B, Lal A. Plasmodium falciparum antigen-induced HIV-1 replication is mediated through induction of TNF-a. J Infect Dis 1998;177:437-45.
69. Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration, AIDS 1999;13:487-94.
70. French N, Nakiyingi J, Lugade E, Watera C, Whitworth J A, Gilks C. Increasing rates of malaria fever with deteriorating immuno status in HIV-1 infected Ugandan adults with. AIDS 2001;15:899-906.
71. Whitworth J, Morgan D, Quigley M, Smith A, Malamba S, Ojwiya A. Effect of HIV-1 and increasing immunosupression on malaria parasitemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000;356:1051-6.
72. Wolde-Amanuel Y. Characterization of Candida albicans strains isolated from Ethiopian and Swedish HIV positive patients. MSc thesis. AAU, 1995.
73. 70a. Aderaye G, Bruchfeld J, Olsson M, Lindquist L. Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia. AIDS 2003;17:435-40.
74. Gebremedhin A. Cryptococcal meningitis in a young Ethiopian woman with AIDS. Ethiop Med J 1992;30:169-73.
75. Wolde-Amanuel Y, Chrysathom E, Petrini B, Abate D. Cryptococcal neoformans isolated from six Ethiopian HIV positive patients with meningitis [Abstract]. Ethiop Med J 1996;34:259.
76. Seboxa T, Alemu S, Assefa A. Cryptococcal meningitis in patients with AIDS [Abstract]. Ethiop Med J 1996;34:258.
77. Wolde-Amanuel Y, Haile T. Cryptococcosis in patients from Tikur Anbessa Hopspital, Addis Ababa, Ethiopia. Ethiop Med J 2001;39:185-91.
78. Gemeda A. Magnitude of STDs problem in Ethiopia. Ministry of Health. Ethiopia. 1990.
79. Geyid A, Tesfaye H, Abraham A, Lemeneh Y, Desta S, Feleke W. Isolates of STD causative agents from sex workers in Addis Ababa (a preliminary report). Ethiop J Health Dev 1990;4:155-61.
80. Desta S, Feleke W, Yosuf M. Prevalence of STD and STD related factors in sex workers of Addis Ababa. Ethiop J Health Dev 1990;4:149-53.
81. Aklilu M, Messele T, Biru T, Tsegaye A, H/Mariam D, van Benthem B, Coutinho R, Rinke de Wit T, Fontanet A. Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS 2001;15:87-96.
82. Kefenie H, Desta B, Mengesha S, Zewdie D, Kebede T. Prevalence of HIV-1 antibodies in patients with STDs. Ethiop Med J 1991;29:63-9.
83. Assefa A, Seroprevalence of HIV-1 and syphillis antibodies in blood donors in Gondar, Ethiopia, 1989-1993. J Acquir Immune Defic Syndr. 1994;7:1282-5.
84. Assefa A. Prevalence of HIV, syphilis and genital chlamydial infection among women in North-West Ethiopia. Infect Epidemiol 1997;118:435-40.
85. Gebre-Kidan K, Fantahun M, Azeze B. Seroprevalence of HIV infection and its association with syphillis seropositivity among antenatal clinic attenders at Debretabor Rural Hospital, Ethiopia. East Afr Med J 1995;72:579-83.
86. Surur F. Descriptive analysis and seroprevalence of HIV among cases of condylomata acuminata. Bull Jimma Ins Health Sci 1997;7:113-20.
87. Atakelti A, Kebede B, Yeneneh H. Pelvic abscess and HIV infection: seroprevalence and risk factors [Abstract]. Ethiop Med J 1996;34:260.
88. Atakelti A, Kebede B, Yeneneh H. The impact of HIV infection on treatment outcome on pelvic abscess cases: a prospective cohort study in Addis Ababa teaching hospitals, Ethiopia [Abstract]. Ethiop Med J 1996;34:259-60.
89. Mihret W, Rinke de Wit TF, Petros B, et al. Herpes simplex virus type 2 seropositivity among urban adults in Africa: Results from two cross-sectional surveys in Addis Ababa, Ethiopia. Sex Transm Dis 2002;29:175-81.
90. Grosskurth H, Mosha F, Todd J, et al. Impact of improved STD treatment on HIV infection in rural Tanzania: a randomised, controlled trial. Lancet 1995;346:530-6.
91. Wolday D, G/Mariam Z, Mohammed Z, et al. The impact of syndromic treatment of sexually transmitted diseases on cervical shedding of HIV-1. XIV International AIDS Conference 2002, Barcelona (Spain).
92. Grant AD, Kaplan JE, De Cock KM. Preventing opportunistic infections among HIV-infected adults in African countries. Am J Trop Med Hyg 2001;65:810-21.